Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
16, Jan
Ipamorelin with CJC-1295 Combining ipamorelin and CJC 1295, a peptide that stimulates pituitary gland function, increases growth hormone release
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
What was the Pliva clinical program for BPC-157
Reconstitution technique matters
US$ 21.61
US$ 20.08
US$ 22.14
US$ 29.11
US$ 26.22
US$ 22.05
US$ 24.97
US$ 24.11
US$ 23.55
US$ 21.51
